Valsartan-BP

Valsartanum

Each film-coated tablet contains valsartan 160 mg.

Each film-coated tablet contains valsartan 80 mg.

Indication: Valsartan-BP is indicated for treatment of hypertension in adults, children and adolescents aged 6 to 18 years; for treatment of clinically stable patients with symptomatic heart failure or asymptomatic left ventricular systolic dysfunction after a recent myocardial infarction; and for treatment of adult patients with symptomatic heart failure when ACE inhibitors are not tolerated, or in patients intolerant to beta-blockers, as add-on therapy to ACE inhibitors when mineralocorticoid receptor antagonists cannot be used.

Contraindications (SmPC sec. 4.3): 4.3 Contraindications - Hypersensitivity to valsartan or to any of the excipients listed in section 6.1. - Severe hepatic impairment, biliary cirrhosis and cholestasis. - Second and third trimester of pregnancy (see sections 4.4 and 4.6). - Concomitant use of Valsartan-BP with medicinal products containing aliskiren is contraindicated in patients with diabetes mellitus or renal impairment (GFR